SCHEMBL1038051

SCHEMBL1038051

Cc1cc(C)c(C(=O)P(CCOCc2ccccc2)C(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ATM Q13315 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
HCAR2 Q8TDS4 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.36
TACR1 P25103 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1037678 0.78 LMNA (0.42) LMNANPC1RAB9AKMT2AMEN1
SCHEMBL1037233 0.75 CETP (0.38) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL1037184 0.72 LMNA (0.38) ALDH1A1LMNARAB9AKMT2AMEN1
SCHEMBL20636994 0.71 NPSR1 (0.40) ALDH1A1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL12691361 0.71 LMNA (0.56) ALDH1A1LMNANPC1KMT2AMEN1
SCHEMBL15636945 0.71 HSD11B1 (0.47) ALDH1A1LMNAKMT2AMEN1L3MBTL1
SCHEMBL1037385 0.70 KMT2A (0.46) ALDH1A1LMNANPC1RAB9AKMT2A
SCHEMBL12956434 0.70 LMNA (0.40) ALDH1A1LMNARAB9AKMT2AMEN1
SCHEMBL25910689 0.69 TDP1 (0.49) ALDH1A1LMNANPC1RAB9AKMT2A
SCHEMBL28668519 0.69 MEN1 (0.35) LMNAKMT2AMEN1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814891-B1 BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES BASF SE (DE) 2011-01-26 EP disclosed
EP-1814891-B1 BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES BASF SE (DE) 2011-01-26 EP disclosed
US-7687657-B2 Process for preparing acylphosphanes and derivatives thereof CIBA SPECIALITY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-7687657-B2 Process for preparing acylphosphanes and derivatives thereof CIBA SPECIALITY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-7687657-B2 Process for preparing acylphosphanes and derivatives thereof CIBA SPECIALITY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof IGM GROUP B.V. (NL) 2008-01-03 US disclosed
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof IGM GROUP B.V. (NL) 2008-01-03 US disclosed
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof IGM GROUP B.V. (NL) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof ME2, ME3, MEP1A ALDH1A1 248/4885LMNA 1081/4885NPC1 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.